tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

MRK Stock Latest News

Merck discontinues vibostolimab-Keytruda combination arm of Phase 3 trial
The FlyMerck discontinues vibostolimab-Keytruda combination arm of Phase 3 trial
3d ago
MRK
Merck provides update on Phase 3 KEYNOTE-B21 trial
PremiumThe Fly
Merck provides update on Phase 3 KEYNOTE-B21 trial
7d ago
MRK
CytomX Therapeutics, Merck enter CX-801 trial collaboration
PremiumThe Fly
CytomX Therapeutics, Merck enter CX-801 trial collaboration
8d ago
MRK
CTMX
Merck: KEYNOTE-811 trial meets dual primary endpoint of OS
PremiumThe Fly
Merck: KEYNOTE-811 trial meets dual primary endpoint of OS
15d ago
MRK
FTC expands patent listing challenges for drugs
PremiumThe Fly
FTC expands patent listing challenges for drugs
16d ago
AZN
BMY
Merck price target raised to $150 from $135 at BofA
PremiumThe FlyMerck price target raised to $150 from $135 at BofA
20d ago
MRK
Merck price target raised to $140 from $135 at Wells Fargo
PremiumThe Fly
Merck price target raised to $140 from $135 at Wells Fargo
20d ago
MRK
Merck price target raised to $143 from $142 at Truist
PremiumThe Fly
Merck price target raised to $143 from $142 at Truist
20d ago
MRK
MRK Earnings: Merck Delivers Q1 Earnings Beat
PremiumMarket News
MRK Earnings: Merck Delivers Q1 Earnings Beat
21d ago
MRK
Options Volatility and Implied Earnings Moves Today, April 25, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, April 25, 2024
21d ago
MO
MRK
Merck raises FY24 adjusted EPS view to $8.53-$8.65 from $8.44-$8.59
PremiumThe Fly
Merck raises FY24 adjusted EPS view to $8.53-$8.65 from $8.44-$8.59
21d ago
MRK
Merck reports Q1 adjusted EPS $2.07, consensus $1.87
PremiumThe Fly
Merck reports Q1 adjusted EPS $2.07, consensus $1.87
21d ago
MRK
Notable companies reporting before tomorrow’s open
PremiumThe FlyNotable companies reporting before tomorrow’s open
21d ago
LH
MO
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
21d ago
LH
MO
MRK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
MRK Upcoming Earnings Report: What to Expect?
23d ago
MRK
Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, April 22 – April 26, 2024
24d ago
F
T
Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential
PremiumMarket News
Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential
1M ago
MRK
MRNA
Merck price target raised to $143 from $140 at Berenberg
PremiumThe Fly
Merck price target raised to $143 from $140 at Berenberg
1M ago
MRK
Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call
PremiumThe Fly
Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call
1M ago
MRK
GOSS
Merck initiates Phase 3 clinical trial of MK-1084
PremiumThe FlyMerck initiates Phase 3 clinical trial of MK-1084
1M ago
MRK
Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial
PremiumThe Fly
Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial
1M ago
MRK
Merck price target raised to $142 from $139 at Truist
PremiumThe Fly
Merck price target raised to $142 from $139 at Truist
2M ago
MRK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >